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This study describes deep sedations performed for painful procedures completed in the emergency
department at an academic tertiary care hospital during an 18-month period. One hundred consecutive
cases were retrospectively reviewed to describe indications, complications, procedural lengths,
medication dosing, and safety of these sedations. Propofol and etomidate were the preferred agents.
We found that there were relatively few complications (10%), with only 2 of these (2%) being major
complications. All complications were brief and did not adversely affect patient outcomes. This data
further demonstrate the safety profile of deep sedation medications in the hands of emergency
physicians trained in sedation and advanced airway techniques. [West J Emerg Med. 2011;12(4):399–
403.]
INTRODUCTION
Once only the purview of anesthesiologists and critical
care specialists, deep sedative medications have been used in
the emergency department (ED) for the last decade. The use of
these medications has stemmed from the understanding that
many procedures in the ED are extremely painful and that
minimal to moderate sedation leads to inadequate management
of the patient’s pain. To this end, several studies have been
completed using deep sedative medications such as propofol
and etomidate. Their use has been shown to be safe and
effective for procedural sedation within the ED.
1–18 However,
many residency-trained and board-certiﬁed emergency
physicians are still unable to use these medications because of
local hospital policies or regulations forbidding anything
greater than ‘‘conscious’’ or moderate sedation. The American
Society of Anesthesiologists’ practice guidelines state,
‘‘Because sedation/analgesia constitutes a continuum,
practitioners...intending to administer deep sedation should be
able to rescue patients who enter a state of general anesthesia.
Therefore...the consultants strongly agree with the immediate
availability (1–5 min away) of an individual with advanced life
support skills (eg tracheal intubation, deﬁbrillation, and use of
resuscitation medications) for moderate sedation and in the
procedure room itself for deep sedation.’’
19 Since tracheal
intubation is a basic skill of the emergency physician, it is
reasonable and appropriate that deep sedation be considered an
essential emergency physician skill. This study will contribute
further support to the literature by describing deep sedation
used by emergency medicine physicians in an academic
medical center ED over the course of 18 months.
METHODS
After obtaining institutional review board approval and
waived consent, we performed a retrospective review of deep
sedations performed in the ED over the course of 18 months.
The records for this review were obtained through a search of
the departmental sedation log and the electronic medical
records for this time period. Sedation levels were considered
deep sedation from the providers’documentation as such in the
medical record. The total number of deep sedations performed
during this time period was 100 and there were no charts
excluded from this review. The only medications used for deep
sedation in the ED during this time period were propofol and
etomidate. All sedations occurred under the direct supervision
of an emergency medicine residency-trained or board-certiﬁed
emergencyphysician. Datawere obtainedby2 of theauthors by
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deﬁned before the review process began. They independently
reviewed the electronic medical records, sedation notes,
nursing ﬂow sheets, and paper records when available. As
determined by the protocol, all missing data were given worst
case numbers. For instance, if the end of the procedure was not
documented, but the time back to baseline mental status was
recorded, we labeled the end of the procedure as the time back
to baseline with the understanding that this would most likely
make our procedural lengths appear longer than in reality. Data
were recorded on an Excel (Microsoft Corp, Redmond,
Washington) spreadsheet by using a code list that was
generated to protect private health information. The data were
analyzed using SPSS (SPSS Inc, Chicago, Illinois).
Complications were deﬁned as major or minor. Major
complications were deﬁned as apnea, oxygen saturation levels
less than 80% at any time, oxygen saturation levels less than
90% for greater than 5 minutes, aspiration, dysrhythmia,
unanticipated admission, need for bag-valve-mask (BVM)
ventilation, or need for intubation. Minor complications were
deﬁned as oxygen saturation levels less than 90% for less than
5 minutes, vomiting without aspiration, need for airway
manipulation such as jaw thrust or nasal trumpet insertion, a
requirement for increased oxygen delivery, transient blood
pressure decrease, or myoclonus (although it is a known side
effect of etomidate).
RESULTS
Of the 100 consecutive deep sedation cases reviewed,
etomidate was used in 60 of the cases and propofol in the other
40 cases. Demographic features differed between the 2 groups.
Patient age ranged from 11 to 85 years (mean, 41 years) in the
etomidate group, and 2 to 73 years (mean, 21.9 years) in the
propofol group. Mean weight demonstrated a nearly 30-kg
difference between the propofol (58.6 kg; range, 10.6–110 kg)
and etomidate (86.6 kg; range, 32–150 kg) groups. The
indications for sedation in the 2 groups are displayed in Table 1.
Most patients (84%) had fasted for more than 4 hours
before sedation (Table 2). Five patients (5%) had fasted for less
than 2 hours and 10 (10%) had fasted between 2 and 4 hours.
Of those sedations completed on individuals fasting less than 4
hours, there were no episodes of vomiting or aspiration. One
major and 1 minor complication occurred in the group fasting
less than 4 hours. The major complication involved a patient
who had a last meal between 2 and 4 hours before the sedation
and required less than 1 minute of BVM ventilation for an
oxygen desaturation to 90%. No vomiting or aspiration
occurred and intubation was not necessary. This patient had an
ankle dislocation for which the beneﬁts of timely relocation
were considered greater than the potential risk of aspiration.
The minor complication involved a brief systolic blood
pressure drop of 20% in a patient who had also fasted between
2 and 4 hours. There was 1 patient for whom time from last
meal was not documented. There were no complications in
those individuals fasting less than 2 hours.
The average dose of the drugs, as well as mean procedural
length and mean time to return to baseline mentation, are
shown in Table 3. For the 60 etomidate cases, there were 6
missing data points for procedural length and 7 missing data
points for time to baseline mentation. These missing data points
were omitted from analysis aswewere unable to ﬁnd any useful
associated times (ie, discharge time, procedure end time, or any
other documentation specifying a return to baseline mentation).
Therewere no missing data points for cases involving propofol.
This relatively thorough collection of data points was the result
of speciﬁc physician and nursing sedation notes, checklists,
and electronic medical records used to record data. These notes
speciﬁcally mandate the recording of the time of the last meal,
complications as previously described, and interventions
performed for sedation or airway issues such as increased
oxygen delivery, airway manipulation, respiration assistance
with BVM, or use of reversal agents. Furthermore, vital signs
are recorded electronically into a nursing ﬂow sheet. Length of
procedure, however, is not a mandated data item in the notes.
The complications for each of the medications are listed in
Table 4. There was a 10% complication rate (6 of 60 cases)
noted in those patients receiving etomidate. Two of these
(3.3%) were considered major complications because they
required BVM ventilation, but each episode lasted less than 1
minute. The remaining 4 (6.7%) were minor complications,
Table 1. Indications for use of deep sedatives.
Indications for sedation
No. of
cases
Etomidate,
No.
Propofol,
No.
Dislocation reduction 39 25 14
Fracture reduction 30 16 14
Electrical cardioversion 16 16 0
Chest tube thoracostomy 5 3 2
Abscess incision and drainage 3 0 3
Computed tomography scan 3 0 3
Foreign body removal—eye 1 0 1
Lumbar puncture 1 0 1
Foley catheter placement 1 0 1
Laceration repair 1 0 1
Table 2. Fasting data.
Time from last meal, h Etomidate, No. Propofol, No.
0–2 3 2
2–4 8 2
4–6 13 13
. 63 5 2 3
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trumpet insertion with subsequent resolution of hypoxia. This
patient’s oxygen saturation dropped to 89% for less than 10
seconds and no other complications occurred. The ﬁnal 3
minor complications involved emesis, with 1 case occurring
during the procedure and the other 2 occurring in the
postprocedural period. In all 3 of these cases, there was no
aspiration and all nausea was resolved with antiemetics.
There was a 10% complication rate (4 of 40 cases) for
patients receiving propofol. There were no major
complications. There were 4 (10%) minor complications. One
involved increasing the oxygen delivery from 4-L oxygen by
nasal cannula to a nonrebreather mask for an oxygen saturation
of 90% that ‘‘quickly improved’’ without any other time
speciﬁed. The other 3 minor complications were transient
decreases in systolic blood pressure (SBP). Two patients had
SBPs less than 90 mmHg and 1 had a 20% drop in SBP from
the initial measurement, dropping from 121 to 101 mmHg. The
2 patients with SBP drops below 90 mmHg required normal
saline boluses (1,000 mL and 700 mL), while the third (20%
SBP reduction) required no intervention.
DISCUSSION
In July 2005, the emergency physicians at our institution
were granted the privilege to perform deep sedation for
emergent and urgent procedures within the ED. Emergency
physicians and nurses were trained on the proper approach to
deep sedation and the details of the deep sedative agents. We
recommended that our physicians use an initial dose of
etomidate of 0.1 mg/kg for sedation. We also developed a
propofol-dosing schedule unique to the literature. In an attempt
to decrease the percentage of respiratory depression events
discussed in the literature with 1.0 to 2.0 mg/kg initial boluses
of propofol, we required a dosing protocol beginning with a
0.75 mg/kg bolus of propofol, followed by 0.5 mg/kg boluses
every 1 to 3 minutes as needed. We found that an average of
0.17 mg/kg of etomidate was used per sedation. Most sedations
were initially started with a 0.1 mg/kg bolus, followed by 0.05
mg/kg boluses as needed. We used an average of 2.78 mg/kg of
propofol (approximately 5 separate boluses) per sedation.
The indications for sedation in our population are similar
to those of other studies and include both painful and anxiety-
provoking procedures (Table 2). Our physicians used etomidate
exclusively in patients in need of electrical cardioversion.
Fracture and dislocation reductions were also common
indications for sedation. Both drugs were used in these
situations and the literature indicates no preference, although
etomidate may have a lower rate of procedural success and
causes a greater incidence of myoclonus.
18
Our review demonstrates that most of our deep sedations
were completed on patients who were fasting for more than 4
hours, but about 15% were completed on patients with food
intake within 4 hours. To maximize patient safety, emergency
physicians ask about last food intake, but in reality there are no
data to support a speciﬁed period of fasting. The American
College of Emergency Physicians’ guideline on procedural
sedation states, ‘‘Recent food intake is not a contraindication
for administering procedural sedation and analgesia, but should
be considered in choosing the timing and target level of
sedation.’’
20 Given the potentially signiﬁcant morbidity and
Table 3. Dosing, procedure length, and sedation length.
Agent N Mean Standard deviation
Average dose, mg/kg Etomidate 60 0.17 0.11
Propofol 40 2.78 2.10
Procedure length, min Etomidate 54 12.49 14.20
Propofol 40 22.05 17.89
Time to baseline, min Etomidate 53 23.87 18.50
Propofol 40 33.65 21.82
Table 4. Complications for each medication.
Major complication Minor complication
Etomidate
(n ¼ 60)
Hypoxia requiring bag-valve-mask ventilation for
less than 1 minute (n ¼ 2)
Hypoxia requiring airway repositioning and nasal trumpet (n ¼ 1)
Emesis without aspiration (n ¼ 3)
Propofol
(n ¼ 40)
None Oxygen saturation of 90% requiring increased oxygen delivery (n ¼ 1)
Transient decrease in SBP of less than 90 mmHg (n ¼ 2)
Transient 20% decrease in SBP from 121 to 101 mmHg (n ¼ 1)
SBP, systolic blood pressure.
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intake should be considered for each situation, with the risk and
beneﬁts based on the urgency of the potential procedure. Using
guidelines made for nonemergent, elective operative
procedures is impractical and potentially harmful by delaying
timely care in an emergent setting. Green et al
21 recently
published a consensus-based clinical practice advisory
regarding fasting and emergency department sedation. This
advisory attempts to elucidate target levels of sedation depth
and timing in relation to fasting status and individual patient
risk factors. This article will likely deﬁne the standard of
practice for emergency medicine; however, as stated in their
practice advisory, ‘‘it is expected that emergency physicians
will at times appropriately deviate from it according to
individualized judgment and unique clinical circumstances.’’
21
When measuring procedural length and time to baseline
mentation for the 2 medications, there was a signiﬁcant
difference in time for these 2 variables. Mean procedure time
with etomidate was 12.5 minutes and the time to baseline was
23.9 minutes. Propofol use was associated with lengthier
procedure times, with a mean time of 22.1 minutes and an
increased time to baseline mentation of 33.7 minutes. The
reason for this is unknown, but we suspect there are 2 primary
reasons for this difference. First, the patient demographics are
quite different, with younger, lighter patients receiving
propofol. This patient selection may indicate that the
emergency physicians chose propofol for the young person
with a forearm fracture, which takes a longer period of time to
reduce and cast, while choosing etomidate for the older patient
with tenuous vital signs in need of a quick cardioversion.
Second, our reduced dosing algorithm for propofol (0.75 mg/kg
initial bolus, followed by 0.5 mg/kg boluses) probably caused
the time to adequate sedation to increase. Our times for both
etomidate and propofol were longer than reported in the
literature. This is most likely due to the retrospective nature of
the study. We effectively chose to make these times longer by
using sedations that had missing data points. When the speciﬁc
‘‘end-of-procedure’’ or ‘‘back-to-baseline’’ times were not
recorded, we erred with the potentially longer rather than
shorter time period. In some cases, for instance, we used the
time the patient was discharged from the ED as the time for the
end of the procedure and the return to baseline mentation
because no other information was available. Additionally,
procedure length in our study was determined by measuring the
time from when the ﬁrst sedative agent was given to the time
the procedure was documented as ﬁnished. Most values in the
literature use medication induction times, not administration
times, which were not documented in our charts. For this reason
we could not compare our times to those in the literature.
For propofol, our data indicate that we have fewer episodes
of respiratory depression than reported in the literature, with
only 1 case (2.5%) requiring an increase in supplemental
oxygen. Reported values for propofol-induced hypoxia appear
to range from 5% to 50%.
15–17Apnea has been noted to occur in
about 4% of cases. A recent study showed an increase in
supplemental oxygen in 5.5% of propofol sedations and in
BVM use in 4.6%.
18 There has been only 1 reported case
requiring intubation.
15 That patient was subsequently extubated
after 32 minutes with no apparent adverse outcome. We had no
reported episodes of apnea or BVM use in our sample.
Our rate of hypotension with propofol sedations (7.5%)fa ll s
within the range quoted in the literature of 3.5% to 12%.
15–17
These episodes were brief and resolved within a short period of
time or with only a small amount of intravenous ﬂuids. While
hypotension in our patients did not appear clinically signiﬁcant,
caution should be taken when using propofol as a sedative agent
in patients who may not be hemodynamically stable. Similar
considerations should be made with adjuvant medications that
may lower blood pressure, such as fentanyl. Finally, care should
betakennottoadminister propofoltooquickly,ashypotensionis
more likely to occur. Administering each dose within 45 to 60
seconds is the preferred method. In the etomidate sedations
performed at our center, we noted a 10% overall complication
rate. Five percent of the cases involved minor hypoxia, deﬁned
as a pulse oximeter reading measuring less than 90%.T h i s
complication rate is less than the rates cited in the literature, with
oxygen desaturation occurring in 10% to 20% of cases.
10 Of
those 3 cases, 2 resolved with BVM ventilation and the last
resolved with airway repositioning and nasal trumpet insertion.
There were no intubations required for these episodes. A recent
trial comparing propofol and etomidate described the use of
BVM and airway repositioning in etomidate sedations to be
3.8% and 13.3%,r e s p e c t i v e l y .
18
The other complication of etomidate noted in our study
was vomiting. One case occurred during the procedure and 2
cases, postprocedurally. Thesewere not associated with notable
aspiration. Our emesis complication rate of 7.5% with
etomidate falls within the range reported in the literature, which
is approximately 2% to 8%.
22
LIMITATIONS
There are several limitations to this study. The principal
limitation is the retrospective nature of the study. Retrospective
reviews are fraught with inadequacies due to lack of controls,
lack of randomization, inaccuracies in documentation,
incomplete documentation, as well as a potential bias to not
report adverse events. We describe differences between
propofol and etomidate only in the descriptive sense because
there was no direct comparison between these 2 medications.
This study had a relatively small sample size, although on par
for most studies published on sedation. Concurrent use of
analgesics was not standardized among patients and could have
interfered with the results of the study.
CONCLUSION
In conclusion, both etomidate and propofol appear safe for
use in our ED setting when used by board-certiﬁed or
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procedures. The complication rates with these agents were less
than or equal to those reported in the literature. Because such
complications are well within the scope of practice of
emergency physicians, they were recognized and treated
without adverse outcomes. Both medications are noted to
induce respiratory depression, although seemingly less with
propofol in our reduced dosing regimen. Propofol carries a
higher risk of hypotension, and therefore should be used with
caution in select patients.
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